Deaths with measles symptoms in Bangladesh pass 1,314 as vaccination gaps drive a severe resurgence
Measles, once brought under control in Bangladesh through a successful vaccination programme, has returned in severe form. Eight more people have died with measles symptoms in the country. With them, deaths from measles and measles-like illness from 15 March this year to Sunday (15 November) have reached 1,314.
According to the latest Directorate General of Health Services figures, 1,209 of the dead died with measles symptoms and 105 died with laboratory-confirmed measles. In the same period, measles symptoms appeared in 1,414 new people and measles was confirmed in tests of 158 people.
In total since 15 March, suspected cases stand at 248,060 and confirmed cases at 25,269. Gaps in routine vaccination, vaccine supply shortages and weaknesses in public health management have been identified as reasons for the return.
Measles infections are also rising worldwide. According to the US Centers for Disease Control and Prevention (CDC), 5,412 measles cases had been detected in the United States by 12 November, compared with 2,289 in all of 2025. Of those infected, 96 percent had not been vaccinated or their vaccination status was unknown.
According to the Pan American Health Organization (PAHO), 57,666 measles cases were detected in 17 countries and territories of the Americas from January to October 2026. New outbreaks have also appeared in various countries of Europe and Africa.
The World Health Organization (WHO) recommends that at least 95 percent of a population receive two doses to keep measles under control. Yet in 2025 only 84 percent of children worldwide received the first dose and 77 percent the second, leaving huge numbers of children unprotected.
For Bangladesh, a study published in November 2026 in the CDC journal Emerging Infectious Diseases identified several causes. Analysis by researchers from the health directorate and IEDCR says MR vaccine stocks running out in 2024-25, gaps in routine vaccination and the closure of nationwide supplementary vaccination programmes left many children unprotected. The study also says using old population figures to set vaccination targets hid the real shortfall.
The government has formed a three-member commission to investigate allegations of delay, irregularities and administrative failure in vaccine purchase and distribution. The commission has been directed to determine responsibility for the period from 8 August 2024 to 17 February 2026 and report within 60 working days.
Public health expert Dr Mushataq Hossain says vaccination gaps increased infections, but an over-centralised treatment system is one reason for the rising death rate. He believes many deaths could have been avoided with stronger primary care at community level and proper isolation of patients, and has advised treating the outbreak as a public health emergency with more field-level services and funding.
Dr Md Mostafizur Rahman, senior director of icddr,b's infectious diseases division, believes immunity gaps, weak surveillance and management limitations are behind the current situation. He says progress on the first dose but shortfalls in the second have created an at-risk population among children under five. He stressed genome sequencing of samples from every outbreak, adequate vaccine stocks and accurate lists of unvaccinated children.
Children with measles can develop complications such as pneumonia, diarrhoea and brain inflammation, and malnourished children face higher risk. In Bangladesh children are normally given the MR vaccine at nine and 15 months. Considering infections among babies under nine months, the government has adopted a programme to vaccinate from six months of age.
According to WHO, measles vaccination saved about 59 million lives from 2000 to 2024. Yet in 2024 alone about 95,000 people died of measles worldwide, most of them children under five. For Bangladesh, continuity of routine vaccination, adequate vaccine stocks, accurate population-based planning and resolving the field-level vaccinator shortage have been highlighted as urgent.




